2 completed, 2 unknown. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow 68Ga-RM2: new trials by email Literature Review of 68Ga-RM2 trials Research Report on 68Ga-RM2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET/MRI to Stage Prostate Cancer Patients 68Ga-PSMA, 68Ga-RM2 - Prostate Cancer | Phase 2 | Unknown | IRCCS San Raffaele | 50 | 2020-09-09 | 2024-07-03 |
| PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study 68Ga-PSMA, 68Ga-RM2 - Prostate Cancer | Phase 2 | Completed | IRCCS San Raffaele | 60 | 2020-06-03 | 2023-04-10 |
| The LightPath® and 68Ga-RM2 in Breast Cancer Study LightPath® Imaging System and 68Ga-RM2, 68Ga-RM2 - Breast Cancer | Phase 3 | Unknown | Lightpoint Medical Limited | 80 | 2018-11-30 | 2018-11-06 |
| 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer 68Ga-RM2, Magnetic Resonance Imaging, Positron Emission Tomography - Prostate Adenocarcinoma | Phase 2 / Phase 3 | Completed | Andrei Iagaru | 122 | 2015-11-16 | 2023-04-10 |
Prostatic Neoplasms (2) · Breast Neoplasms (1)
IRCCS San Raffaele (2) · Andrei Iagaru (1) · Lightpoint Medical Limited (1)
Italy (2) · United Kingdom (1) · United States (1)
Andrei Iagaru (1) · Qamar B Akbar, MSc (1)